20 - 21 November 2018 | Berlin
Best practice sessions on research and implementation will give successful examples for translation of personalised medicine research into an added value for the patient, such as the implementation of personalised lung cancer care in clinical routine in Germany or the implementation of personalised medicine for rare diseases and cancer in Sweden. This will be done in a comprehensive approach, giving room for representatives of all relevant steps (e.g. researchers, clinicians, payers, patients) to describe their views and experiences.
Further sessions will encompass examples for policy making and impact analysis on personalised medicine research from the . High-level key note talks on different aspects of personalised medicine will broaden up the conference perspective and provide international views on personalised medicine in China and India. Speakers and lecture topics can be taken from the final programme.
High-level speakers such as Anja Karliczek (German Federal Minister of Education and Research), Jens Spahn (German Federal Minister of Health) and representatives of the European Commission (DG RTD & CNECT) have confirmed their participation.
Registration closed on 9 November 2018. Participation is free of charge.
ICPerMed provides a platform to initiate and support communication and exchange on personalised medicine research, funding and implementation. Thus, ICPerMed will contribute to the reasonable and fair implementation of personalised medicine approaches into the health systems for the benefit of patients, citizens and society as a whole.
The project was initiated during several workshops organised by the European Commission throughout 2016. The basis for this was the previous project, PerMed, that was funded from 2013-2015 by the European Union's 7th Framework Programme and brought together many organisations active in the area.
Tel.: +49 228 3821 1266